tirzepatide cut off FDA approves new version of diabetes drug Mounjaro to be sold for weight loss Zepbound Cuts the Risk of

Not the regular trash

The standard schedule remains once weekly, and the 72-hour minimum is a safety floor for occasional early dosing , not a recommended regular interval

Vascular conditions : Systemic hypertension,, high cholesterol levels, diabetes and hardening of the arteries can reduce blood flow to the optic nerve Anatomical predisposition : Having a small optic disc with a low cup-to-disc ratio creates a crowded disc appearance Nocturnal hypotension : Significant drops in blood pressure during sleep can decrease blood flow to the optic nerve head Sleep apnea : Intermittent episodes of low oxygen levels and problems with blood vessels during sleep increase the risk of ischemia Risk Factors and Complexity Show Why it is Hard to Predict Susceptible Patients: These various risk factors highlight how complex NAION is and why its challenging to predict who will be more susceptible to it

In SURMOUNT-1 (NEJM 2022, 2,539 adults with obesity), the 15 mg arm averaged 22.5% body weight loss at 72 weeks, the 10 mg arm 21.4%, and the 5 mg arm 16.0%

population approve of using these drugs (many of which, like Ozempic, are only approved to treat type 2 diabetes) to treat obesity